Medality Medical™ LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial

MIDLAND PARK, NJ – February 14,2019 – Medality Medical LLC, a U.S.-based medical technology company, announced that it has received U.S. Food & Drug Administration (FDA) Investigational Device Exemption (IDE”) approval to undertake a clinical trial of its patented proprietary medical device and surgical procedure designed to reverse type 2 diabetes and associated obesity. According […]

Medality Medical™ LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial Read More »